🔗 Share this article

Former Prime Minister Rishi Sunak has intensified his campaign for a targeted screening programme for prostate gland cancer.

In a recently conducted conversation, he stated being "certain of the immediate need" of introducing such a system that would be cost-effective, feasible and "save numerous lives".

His statements surface as the National Screening Advisory Body reevaluates its determination from the previous five-year period against recommending routine screening.

News sources suggest the authority may continue with its existing position.

Athlete Contributes Support to Movement

Gold medal cyclist Sir Chris Hoy, who has advanced prostate cancer, wants middle-aged males to be tested.

He suggests reducing the minimum age for accessing a prostate-specific antigen laboratory test.

Presently, it is not automatically provided to men without symptoms who are below fifty.

The prostate-specific antigen screening remains controversial however. Levels can elevate for factors apart from cancer, such as infections, resulting in false positives.

Critics contend this can cause unnecessary treatment and complications.

Focused Testing Proposal

The suggested testing initiative would target individuals in the 45-69 age bracket with a genetic predisposition of prostate gland cancer and African-Caribbean males, who experience increased susceptibility.

This population comprises around 1.3 million men in the Britain.

Organization calculations suggest the programme would necessitate £25 million annually - or about £18 per person per participant - akin to intestinal and breast testing.

The estimate involves one-fifth of qualified individuals would be invited annually, with a 72% response rate.

Medical testing (imaging and tissue samples) would need to increase by twenty-three percent, with only a modest expansion in healthcare personnel, according to the analysis.

Medical Community Reaction

Various clinical specialists remain doubtful about the effectiveness of testing.

They assert there is still a possibility that men will be intervened for the cancer when it is not absolutely required and will then have to live with complications such as bladder issues and sexual performance issues.

One respected urological professional remarked that "The challenge is we can often find conditions that may not require to be addressed and we risk inflicting harm...and my worry at the moment is that negative to positive ratio needs adjustment."

Patient Experiences

Patient voices are also influencing the debate.

A particular instance involves a man in his mid-sixties who, after seeking a PSA test, was detected with the condition at the age of 59 and was advised it had progressed to his pelvis.

He has since experienced chemical therapy, radiotherapy and hormonal therapy but cannot be cured.

The patient endorses testing for those who are at higher risk.

"That is very important to me because of my boys – they are approaching middle age – I want them tested as promptly. If I had been screened at 50 I am sure I would not be in the position I am now," he said.

Next Actions

The National Screening Committee will have to weigh up the data and arguments.

While the recent study indicates the ramifications for personnel and capacity of a examination system would be manageable, others have contended that it would divert scanning capacity away from individuals being cared for for alternative medical problems.

The continuing dialogue underscores the multifaceted trade-off between early detection and possible unnecessary management in prostate gland cancer management.